_id

69105d06ccc777a4e85d5894

Ticker

DRUG

Name

Bright Minds Biosciences Inc

Exchange

NASDAQ

Address

19 Vestry Street, New York, NY, United States, 10013

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://brightmindsbio.com

Description

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatry and neurology indications. Bright Minds Biosciences Inc. has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was founded in 2017 and is headquartered in New York, New York.

Last Close

89.01

Volume

53857

Current Price

83.94

Change

-5.695989214694986

Last Updated

2025-11-29T12:23:20.118Z

Image

data:image/webp;base64,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

Ipo Date

2021-03-22T00:00:00.000Z

Market Cap

496204736

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9793333333333334

Sentiment Sources

3

Rating

4.6667

Target Price

94.0843

Strong Buy

4

Buy

2

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-06-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

3296310

Operating Income

-3296310

Interest Expense

-

Pretax Income

-5242970

Net Income

-5242970

Eps

-0.7401183123229628

Dividends Per Share

-

Shares Outstanding

7088639

Income Tax Expense

-

EBITDA

-3280465

Operating Margin

-

Total Other Income Expense Net

-1946660

Cash

51387560

Short Term Investments

-

Receivables

272634

Inventories

-

Total Current Assets

52368584

Property Plant Equipment

128976

Total Assets

52497560

Payables

510804

Short Term Debt

78188

Long Term Debt

-

Total Liabilities

667833

Equity

51829727

Depreciation

15845

Change In Working Capital

-379479

Cash From Operations

-3503935

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

-16870

Net Change In Cash

-4292356

PE

-

PB

11.06992777071737

ROE

-10.115758471967256

ROA

-9.987073684948406

FCF

-3503935

Fcf Percent

-

Piotroski FScore

1

Health Score

35

Deep Value Investing Score

3.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2.5

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

3

Quarters > 0 > quarter

2025-06-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

3296310

Quarters > 0 > income Statement > operating Income

-3296310

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-5242970

Quarters > 0 > income Statement > net Income

-5242970

Quarters > 0 > income Statement > eps

-0.7401183123229628

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

7083962

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-3280465

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

-1946660

Quarters > 0 > balance Sheet > cash

51387560

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

272634

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

52368584

Quarters > 0 > balance Sheet > property Plant Equipment

128976

Quarters > 0 > balance Sheet > total Assets

52497560

Quarters > 0 > balance Sheet > payables

510804

Quarters > 0 > balance Sheet > short Term Debt

78188

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

667833

Quarters > 0 > balance Sheet > equity

51829727

Quarters > 0 > cash Flow > net Income

-5242970

Quarters > 0 > cash Flow > depreciation

15845

Quarters > 0 > cash Flow > change In Working Capital

-379479

Quarters > 0 > cash Flow > cash From Operations

-3503935

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

-16870

Quarters > 0 > cash Flow > net Change In Cash

-4292356

Quarters > 0 > ratios > PE

-0.7401183123229628

Quarters > 0 > ratios > PB

11.06992777071737

Quarters > 0 > ratios > ROE

-10.115758471967256

Quarters > 0 > ratios > ROA

-9.987073684948406

Quarters > 0 > ratios > FCF

-3503935

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

35

Quarters > 1 > quarter

2025-03-31

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

3352081

Quarters > 1 > income Statement > operating Income

-3352081

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-2950385

Quarters > 1 > income Statement > net Income

-2950385

Quarters > 1 > income Statement > eps

-0.634618867531672

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

4649066

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-3329600

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

401696

Quarters > 1 > balance Sheet > cash

55679916

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

233569

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

56314874

Quarters > 1 > balance Sheet > property Plant Equipment

154513

Quarters > 1 > balance Sheet > total Assets

56469387

Quarters > 1 > balance Sheet > payables

551216

Quarters > 1 > balance Sheet > short Term Debt

77750

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

726812

Quarters > 1 > balance Sheet > equity

55742575

Quarters > 1 > cash Flow > net Income

-2950385

Quarters > 1 > cash Flow > depreciation

22481

Quarters > 1 > cash Flow > change In Working Capital

-138628

Quarters > 1 > cash Flow > cash From Operations

-2425282

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

225383

Quarters > 1 > cash Flow > net Change In Cash

-2216749

Quarters > 1 > ratios > PE

-0.634618867531672

Quarters > 1 > ratios > PB

6.755012708652228

Quarters > 1 > ratios > ROE

-5.292875329135764

Quarters > 1 > ratios > ROA

-5.224751244422044

Quarters > 1 > ratios > FCF

-2425282

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

35

Quarters > 2 > quarter

2024-12-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

1624651

Quarters > 2 > income Statement > operating Income

-1624651

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

49610

Quarters > 2 > income Statement > net Income

49610

Quarters > 2 > income Statement > eps

0.010670960575737147

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

4649066

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-1603118

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

49610

Quarters > 2 > balance Sheet > cash

57896665

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

67021

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

58221636

Quarters > 2 > balance Sheet > property Plant Equipment

176993

Quarters > 2 > balance Sheet > total Assets

58398629

Quarters > 2 > balance Sheet > payables

373629

Quarters > 2 > balance Sheet > short Term Debt

72665

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

571590

Quarters > 2 > balance Sheet > equity

57827039

Quarters > 2 > cash Flow > net Income

49610

Quarters > 2 > cash Flow > depreciation

21533

Quarters > 2 > cash Flow > change In Working Capital

-118561

Quarters > 2 > cash Flow > cash From Operations

-1494394

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

52040905

Quarters > 2 > cash Flow > net Change In Cash

52176573

Quarters > 2 > ratios > PE

0.010670960575737147

Quarters > 2 > ratios > PB

6.5115179516281305

Quarters > 2 > ratios > ROE

0.08579031687927165

Quarters > 2 > ratios > ROA

0.08495062444017307

Quarters > 2 > ratios > FCF

-1494394

Quarters > 2 > ratios > Piotroski FScore

2

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

49

Quarters > 3 > quarter

2024-09-30

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

764460

Quarters > 3 > income Statement > operating Income

-764460

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-749315

Quarters > 3 > income Statement > net Income

-749315

Quarters > 3 > income Statement > eps

-0.1611753844750752

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

4649066

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-772291

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

15145

Quarters > 3 > balance Sheet > cash

5720092

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

50224

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

5986944

Quarters > 3 > balance Sheet > property Plant Equipment

117658

Quarters > 3 > balance Sheet > total Assets

6104602

Quarters > 3 > balance Sheet > payables

407548

Quarters > 3 > balance Sheet > short Term Debt

79384

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

568259

Quarters > 3 > balance Sheet > equity

5536343

Quarters > 3 > cash Flow > net Income

-773441

Quarters > 3 > cash Flow > depreciation

19019

Quarters > 3 > cash Flow > change In Working Capital

93387

Quarters > 3 > cash Flow > cash From Operations

-463170

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

-23557

Quarters > 3 > cash Flow > net Change In Cash

-470152

Quarters > 3 > ratios > PE

-0.1611753844750752

Quarters > 3 > ratios > PB

68.01273016104675

Quarters > 3 > ratios > ROE

-13.534475736058985

Quarters > 3 > ratios > ROA

-12.274592184715727

Quarters > 3 > ratios > FCF

-463170

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

35

Valuation > metrics > PE

-0.7401183123229628

Valuation > metrics > PB

11.06992777071737

Valuation > final Score

20

Valuation > verdict

269.0% Overvalued

Profitability > metrics > ROE

-10.115758471967256

Profitability > metrics > ROA

-10.011670355646812

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.012885134432600812

Risk > metrics > Interest Coverage

-1.6796441282952146

Risk > final Score

53

Risk > verdict

High

Liquidity > metrics > Current Ratio

88.91221612517657

Liquidity > metrics > Quick Ratio

88.91221612517657

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

40

Prev Valuations > 2

20

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

25

Prev Risks > 1

56

Prev Risks > 2

-73

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-12T16:09:46.155Z